​

Merit Medical Systems (MMSI) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

MMSI Stock Forecast

Merit Medical Systems (MMSI) stock forecast, based on 12 Wall Street analysts, predicts a 12-month average price target of $100.78, with a high of $125.00 and a low of $71.00. This represents a 11.27% increase from the last price of $90.57.

$70 $81 $92 $103 $114 $125 High: $125 Avg: $100.78 Low: $71 Last Closed Price: $90.57

MMSI Stock Rating

Merit Medical Systems stock's rating consensus is Buy, based on 12 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 11 Buy (91.67%), 1 Hold (8.33%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 12 0 1 11 Strong Sell Sell Hold Buy Strong Buy

MMSI Price Target Upside V Benchmarks

TypeNameUpside
StockMerit Medical Systems11.27%
SectorHealthcare Stocks 35.25%
IndustryMedical Instruments & Supplies Stocks34.02%

Price Target Trends

1M3M12M
# Anlaysts--10
Avg Price Target--$102.70
Last Closing Price$90.57$90.57$90.57
Upside/Downside--13.39%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 25551--11
Mar, 25451--10
Feb, 25451--10
Jan, 25451--10
Dec, 24552--12
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 15, 2024David RescottRobert W. Baird$107.00$95.5212.02%18.14%
Sep 16, 2024Mike MatsonNeedham$105.00$96.169.19%15.93%
Sep 16, 2024Larry BiegelsenWells Fargo$103.00$96.167.11%13.72%
Sep 16, 2024Craig BijouBank of America Securities$103.00$96.167.11%13.72%
Sep 09, 2024Jason BednarPiper Sandler$110.00$96.5813.90%21.45%
Aug 05, 2024Craig BijouBank of America Securities$92.00$87.445.22%1.58%
Aug 02, 2024Jason BednarPiper Sandler$100.00$86.8615.13%10.41%
Jul 02, 2024John YoungCanaccord Genuity$125.00$85.6445.96%38.01%
Jun 13, 2024Larry BiegelsenWells Fargo$85.00$83.252.10%-6.15%
May 01, 2024Jason BednarPiper Sandler$97.00$77.1225.78%7.10%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Dec 11, 2024Wells FargoBuyOverweightupgrade
Oct 18, 2024Sandler O'NeillUnderperformUnderperformhold
Sep 17, 2024Canaccord GenuityBuyBuyhold
Sep 16, 2024Wells FargoBuyBuyhold
Sep 16, 2024NeedhamBuyBuyhold
Sep 16, 2024Wells FargoEqual-WeightEqual-Weighthold
Sep 16, 2024Bank of America SecuritiesNeutralNeutralhold
Sep 09, 2024Piper SandlerOverweightOverweighthold
Aug 28, 2024NeedhamUnderperformUnderperformhold
Aug 05, 2024Bank of America SecuritiesNeutralNeutralhold

Financial Forecast

EPS Forecast

$-1 $0 $1 $2 $3 $4 $5 $6 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-0.18$0.86$1.31$1.64-----
Avg Forecast$1.56$2.17$2.58$2.97$3.36$3.74$4.20$4.58$5.02
High Forecast$1.59$2.21$2.60$2.99$3.38$3.81$4.51$4.63$5.07
Low Forecast$1.54$2.15$2.55$2.95$3.35$3.69$3.79$4.50$4.92
Surprise %-111.54%-60.37%-49.22%-44.78%-----

Revenue Forecast

$900M $1B $1B $1B $2B $2B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$963.88M$1.07B$1.15B$1.26B$1.30B----
Avg Forecast$956.32M$1.07B$1.15B$1.25B$1.35B$1.48B$1.57B$1.71B$1.83B
High Forecast$970.54M$1.08B$1.16B$1.26B$1.36B$1.49B$1.57B$1.71B$1.85B
Low Forecast$947.86M$1.06B$1.14B$1.24B$1.33B$1.46B$1.57B$1.70B$1.81B
Surprise %0.79%0.71%0.29%0.32%-3.78%----

Net Income Forecast

$-50M $20M $90M $160M $230M $300M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-9.84M$48.45M$74.52M$94.41M-----
Avg Forecast$90.82M$32.76M$45.70M$94.41M$196.43M$218.71M$242.24M$266.43M$292.75M
High Forecast$92.57M$39.32M$54.84M$113.29M$197.31M$222.22M$263.38M$270.30M$295.86M
Low Forecast$89.77M$26.21M$36.56M$75.53M$195.56M$215.20M$221.11M$262.56M$287.39M
Surprise %-110.84%47.89%63.05%------

MMSI Forecast FAQ

Is Merit Medical Systems stock a buy?

Merit Medical Systems stock has a consensus rating of Buy, based on 12 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 11 Buy, 1 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Merit Medical Systems is a favorable investment for most analysts.

What is Merit Medical Systems's price target?

Merit Medical Systems's price target, set by 12 Wall Street analysts, averages $100.78 over the next 12 months. The price target range spans from $71 at the low end to $125 at the high end, suggesting a potential 11.27% change from the previous closing price of $90.57.

How does Merit Medical Systems stock forecast compare to its benchmarks?

Merit Medical Systems's stock forecast shows a 11.27% upside, underperforming the average forecast for the healthcare stocks sector (35.25%) and underperforming the medical instruments & supplies stocks industry (34.02%).

What is the breakdown of analyst ratings for Merit Medical Systems over the past three months?

  • April 2025: 45.45% Strong Buy, 45.45% Buy, 9.09% Hold, 0% Sell, 0% Strong Sell.
  • March 2025: 40.00% Strong Buy, 50.00% Buy, 10.00% Hold, 0% Sell, 0% Strong Sell.
  • February 2025: 40.00% Strong Buy, 50.00% Buy, 10.00% Hold, 0% Sell, 0% Strong Sell.

What is Merit Medical Systems’s EPS forecast?

Merit Medical Systems's average annual EPS forecast for its fiscal year ending in December 2025 is $3.74, marking a 0% decrease from the reported $0 in 2024. Estimates for the following years are $4.2 in 2026, $4.58 in 2027, and $5.02 in 2028.

What is Merit Medical Systems’s revenue forecast?

Merit Medical Systems's average annual revenue forecast for its fiscal year ending in December 2025 is $1.48B, reflecting a 13.43% increase from the reported $1.3B in 2024. The forecast for 2026 is $1.57B, followed by $1.71B for 2027, and $1.83B for 2028.

What is Merit Medical Systems’s net income forecast?

Merit Medical Systems's net income forecast for the fiscal year ending in December 2025 stands at $218.71M, representing a 0% decrease from the reported $0 in 2024. Projections indicate $242.24M in 2026, $266.43M in 2027, and $292.75M in 2028.